Anti-SARS-CoV-2 Monoclonal Antibody News

As of February 9, 2022, the latest anti-SARS-CoV-2 monoclonal antibody (mAbs) breaking news is published at Precision Vaccinations.

There are anti-SARS mAbs products Authorized by the U.S. FDA to treat certain patients. Furthermore, the U.S. NIH continues to identify which mAbs is most effective against the Omicron variant.

Since September 13, 2021, the U.S. government has distributed about 3.3 million mAbs treatments to states, territories, and agencies.